Corporate

Represented Unifrax (USA), Sinochem International, Whirlpool (China), and other enterprises in acquisitions of controlling stakes in domestic A-share and overseas listed companies, public tender offers, and share-swap absorption mergers.

Represented CMOC and BHR, Shanghai Electric, the Yuwell Technology consortium, and Media.net shareholders in major overseas asset acquisitions in mining and energy, cross-border acquisitions of overseas medical device enterprises, and equity sales of global internet technology assets.

Represented the Summitview Capital consortium, Warburg Pincus, Gaw Capital, and other institutions in the privatization of overseas listed companies (such as ISSI) and subsequent restructuring and exit through sale to A-share listed companies, as well as the asset spin-offs and restructuring of large project companies.

Represented Envision Group, Bosideng, DNE, and other enterprises in the establishment of major joint ventures, concentration of undertakings (antitrust) filings, structuring of cross-border business operations, and the formation of strategic cooperation platforms with insurance capital.

Represented IM Motors, UNISOC, MetaX, Jieti Medical, Univista, Melon Smart, Momo Dim Sum, and multiple other high-growth enterprises in various rounds of large-scale equity financing and the introduction of preferred shares.

Represented Ant Group, Alibaba Health, Shanghai Integrated Circuit Industry Investment Fund, China Internet Investment Fund, PICC Capital, CDH Investments, and other institutions in their strategic equity investment projects in Shouqianba, OptoMedic, SMSC, Seeya Technology, and multiple other enterprises.